BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 26200229)

  • 1. A glycoprotein E gene-deleted bovine herpesvirus 1 as a candidate vaccine strain.
    Weiss M; Brum MC; Anziliero D; Weiblen R; Flores EF
    Braz J Med Biol Res; 2015 Sep; 48(9):843-51. PubMed ID: 26200229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection induced by a glycoprotein E-deleted bovine herpesvirus type 1 marker strain used either as an inactivated or live attenuated vaccine in cattle.
    Romera SA; Puntel M; Quattrocchi V; Del Médico Zajac P; Zamorano P; Blanco Viera J; Carrillo C; Chowdhury S; Borca MV; Sadir AM
    BMC Vet Res; 2014 Jan; 10():8. PubMed ID: 24401205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction and growth properties of bovine herpesvirus type 5 recombinants defective in the glycoprotein E or thymidine kinase gene or both.
    Brum MC; Weiblen R; Flores EF; Chowdhury SI
    Braz J Med Biol Res; 2010 Feb; 43(2):217-24. PubMed ID: 19893987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A triple gene mutant of BoHV-1 administered intranasally is significantly more efficacious than a BoHV-1 glycoprotein E-deleted virus against a virulent BoHV-1 challenge.
    Chowdhury SI; Wei H; Weiss M; Pannhorst K; Paulsen DB
    Vaccine; 2014 Sep; 32(39):4909-15. PubMed ID: 25066735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of an inactivated, recombinant bovine herpesvirus type 5 (BoHV-5) vaccine.
    Campos FS; Dezen D; Antunes DA; Santos HF; Arantes TS; Cenci A; Gomes F; Lima FE; Brito WM; Filho HC; Batista HB; Spilki FR; Franco AC; Rijsewijk FA; Roehe PM
    Vet Microbiol; 2011 Feb; 148(1):18-26. PubMed ID: 20828945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraspecific bovine herpesvirus 1 recombinants carrying glycoprotein E deletion as a vaccine marker are virulent in cattle.
    Muylkens B; Meurens F; Schynts F; Farnir F; Pourchet A; Bardiau M; Gogev S; Thiry J; Cuisenaire A; Vanderplasschen A; Thiry E
    J Gen Virol; 2006 Aug; 87(Pt 8):2149-2154. PubMed ID: 16847110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological characterization of bovine herpesvirus 1 recombinants possessing the vaccine glycoprotein E negative phenotype.
    Muylkens B; Meurens F; Schynts F; de Fays K; Pourchet A; Thiry J; Vanderplasschen A; Antoine N; Thiry E
    Vet Microbiol; 2006 Mar; 113(3-4):283-91. PubMed ID: 16321480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunization and challenge experiments with a new modified live bovine herpesvirus type 1 marker vaccine prototype adjuvanted with a co-polymer.
    Kalthoff D; König P; Trapp S; Beer M
    Vaccine; 2010 Aug; 28(36):5871-7. PubMed ID: 20600486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and validation of a triplex real-time PCR assay for the rapid detection and differentiation of wild-type and glycoprotein E-deleted vaccine strains of Bovine herpesvirus type 1.
    Wernike K; Hoffmann B; Kalthoff D; König P; Beer M
    J Virol Methods; 2011 Jun; 174(1-2):77-84. PubMed ID: 21458493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of an epitope within the Bovine herpesvirus 1 glycoprotein E cytoplasmic tail and use of a monoclonal antibody directed against the epitope for the differentiation between vaccinated and infected animals.
    Chowdhury SI
    J Virol Methods; 2016 Jul; 233():97-104. PubMed ID: 26976821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term study (2005-2010) on the vaccination with BoHV-1 glycoprotein E-deleted marker vaccine in selected two dairy herds in Turkey.
    Alkan F; Bilge-Dagalp S; Karapınar Z; Timurkan MO; Coskun N; Burgu I
    Trop Anim Health Prod; 2018 Feb; 50(2):353-363. PubMed ID: 29071668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction and characterization of a glycoprotein E gene-deleted bovine herpesvirus type 1 recombinant.
    Chowdhury SI; Ross CS; Lee BJ; Hall V; Chu HJ
    Am J Vet Res; 1999 Feb; 60(2):227-32. PubMed ID: 10048557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction, characterization and immunogenicity of a glycoprotein E negative bovine herpesvirus-1.1 Egyptian strain "Abu-Hammad".
    El-Kholy AA; Rady DI; Abdou ER; Elseafy MM; Abdelrahman KA; Soliman H
    J Virol Methods; 2013 Dec; 194(1-2):74-81. PubMed ID: 23962750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A live, attenuated pseudorabies virus strain JS-2012 deleted for gE/gI protects against both classical and emerging strains.
    Tong W; Li G; Liang C; Liu F; Tian Q; Cao Y; Li L; Zheng X; Zheng H; Tong G
    Antiviral Res; 2016 Jun; 130():110-7. PubMed ID: 26946112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A recombinant bovine herpesvirus-4 vectored vaccine delivered via intranasal nebulization elicits viral neutralizing antibody titers in cattle.
    Williams LBA; Fry LM; Herndon DR; Franceschi V; Schneider DA; Donofrio G; Knowles DP
    PLoS One; 2019; 14(4):e0215605. PubMed ID: 31002724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant Bovine Herpesvirus Type I Expressing the Bovine Viral Diarrhea Virus E2 Protein Could Effectively Prevent Infection by Two Viruses.
    Liu CY; Guo H; Zhao HZ; Hou LN; Wen YJ; Wang FX
    Viruses; 2022 Jul; 14(8):. PubMed ID: 35893683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virulence, immunogenicity and reactivation of bovine herpesvirus 1 mutants with a deletion in the gC, gG, gI, gE, or in both the gI and gE gene.
    Kaashoek MJ; Rijsewijk FA; Ruuls RC; Keil GM; Thiry E; Pastoret PP; Van Oirschot JT
    Vaccine; 1998 May; 16(8):802-9. PubMed ID: 9627937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attenuation of bovine herpesvirus type 1 by deletion of its glycoprotein G and tk genes and protection against virulent viral challenge.
    Zhang M; Fu S; Deng M; Xie Q; Xu H; Liu Z; Hu C; Chen H; Guo A
    Vaccine; 2011 Nov; 29(48):8943-50. PubMed ID: 21959327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune responses in bovines to recombinant glycoprotein D of bovine herpesvirus type 5 as vaccine antigen.
    Araujo IL; Dummer LA; Rodrigues PRC; Dos Santos AG; Fischer G; Cunha RC; Leite FPL
    Vaccine; 2018 Nov; 36(50):7708-7714. PubMed ID: 30381153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A recombinant bovine herpesvirus 5 defective in thymidine kinase and glycoprotein E is immunogenic for calves and confers protection upon homologous challenge and BoHV-1 challenge.
    Anziliero D; Santos CM; Brum MC; Weiblen R; Chowdhury SI; Flores EF
    Vet Microbiol; 2011 Dec; 154(1-2):14-22. PubMed ID: 22019288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.